KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Enterprise Value (2016 - 2026)

Medtronic's Enterprise Value history spans 14 years, with the latest figure at -$8.2 billion for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 6.21% to -$8.2 billion in Q1 2026 year-over-year; TTM through Jan 2026 was -$8.2 billion, a 6.21% decrease, with the full-year FY2025 number at -$8.7 billion, down 11.98% from a year prior.
  • Enterprise Value hit -$8.2 billion in Q1 2026 for Medtronic, down from -$8.1 billion in the prior quarter.
  • Over the last five years, Enterprise Value for MDT hit a ceiling of -$7.5 billion in Q4 2023 and a floor of -$11.3 billion in Q4 2022.
  • Historically, Enterprise Value has averaged -$8.7 billion across 5 years, with a median of -$8.1 billion in 2024.
  • Biggest five-year swings in Enterprise Value: soared 32.93% in 2023 and later fell 11.98% in 2025.
  • Tracing MDT's Enterprise Value over 5 years: stood at -$11.3 billion in 2022, then soared by 32.93% to -$7.5 billion in 2023, then fell by 2.92% to -$7.8 billion in 2024, then dropped by 4.58% to -$8.1 billion in 2025, then dropped by 0.6% to -$8.2 billion in 2026.
  • Business Quant data shows Enterprise Value for MDT at -$8.2 billion in Q1 2026, -$8.1 billion in Q4 2025, and -$7.9 billion in Q3 2025.